ENDO 2025 Abstract

SUN-691 Permeate: A Novel Platform for Enhanced Incretin Peptide Bioavailability

By Patrick Derrian Susilo, Mary Ashley Hudson, Maria Kanelli, Vasu Sethuraman

Experiments in animalsInterventions

The paper

Syntis Bio

ENDO 2025 Abstract, 22 Oct 2025, CC BY-NC-ND

Presented at ENDO 2025

doi.org/10.1210/jendso/bvaf149.198

The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
Lancet4 Oct 2026
Orforglipron matches insulin glargine on cardiovascular safety
Research Square8 Oct 2026
Semaglutide improved heart artery function in pigs